cGMP Manufacture

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Albumedix Completes Commercial-Scale Mfg. Facility Expansion

Will service increasing demand for products and technologies for cell and gene therapies, vaccines, diagnostics, protein and peptide therapeutics.

Kristin Brooks 04.14.21

cGMP Manufacture | QA/QC

Ensuring Pharma Manufacturing Quality

How today’s life sciences manufacturers can effectively monitor processes, integrate with sub-contractors and align with regulatory reporting requirements.

Online Exclusives Kristin Brooks, Contract Pharma 04.14.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Catalent Biologics Completes Madison Expansion

More than doubles overall CGMP-scale capacity increasing the number of manufacturing suites at the site to five.

Kristin Brooks 04.13.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Industry News

Moderna, Catalent Enter Long-Term Strategic Vax Pact

Catalent to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs.

Kristin Brooks 04.06.21

Enteris BioPharma: Custom Solutions – From Bench to Market

CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.

Sponsored released by Enteris BioPharma 04.01.21

APIs | Breaking News | cGMP Manufacture | Industry News

Piramal Pharma to Acquire Indian API Manufacturer Hemmo

Adds peptide API development and manufacturing capabilities for growing number of oncology and metabolic therapies.

Kristin Brooks 04.01.21

Breaking News | cGMP Manufacture | Fill/Finish | Industry News

AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement

Expands scope of Aji Bio-Pharma's service offerings to include aseptic fill finish services at its San Diego, CA facility.

Kristin Brooks 03.30.21

Breaking News | cGMP Manufacture | Fill/Finish | Industry News

GRAM Attains EU GMP Certification for Commercial Aseptic Fill/Finish

Recognizes manufacturing facility and processes are in compliance with GMP requirements and readiness to provide commercial aseptic fill/finish services.

Kristin Brooks 03.30.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

CureVac, Celonic Enter COVID-19 Vax Mfg. Pact

Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year at Heidelberg facility.

Kristin Brooks 03.30.21

Biologics, Proteins, Vaccines | cGMP Manufacture

Advanced Analytics Advancing Development of Genetic Vaccines

Leveraging innovative advanced analytical technologies to ensure regulatory compliance in the development and production of novel vaccines.

Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 03.29.21

Chime Biologics Expands CDMO Capabilities

Completes $190 million financing round to accelerate capacity expansion.

Tim Wright, Editor, Contract Pharma 03.29.21

Breaking News | cGMP Manufacture | Industry News

EMA Approves BioNTech's COVID Vax Production at Marburg Site

Largest mRNA vaccine manufacturing site in Europe has annual production capacity of up to one billion doses of its COVID-19 vaccine.

Kristin Brooks 03.26.21

mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity

Utilizing ABEC Custom Single Run technology to increase flexibility and productivity.

Tim Wright, Editor, Contract Pharma 03.25.21

cGMP Manufacture | Drug Development | Scale-up/Technology Transfer

Fast Track Automation in Pharmaceutical Manufacturing

Drug manufacturers turn to advanced automation technologies and project execution methodologies to reduce time, cost and risk

Steve Zarichniak, Technical Solutions Consultant, Honeywell Process Solutions 03.25.21

CyanVac and Exothera Enter COVID-19 Vaccine Partnership

CDMO Exothera selected for the development and GMP manufacturing of intranasal vaccine candidate for Phase III clinical trial is Europe and the U.S.

Tim Wright, Editor, Contract Pharma 03.25.21

Breaking News | cGMP Manufacture | Collaborations & Alliances

BioCentriq, Kytopen Enter Cell Therapy Alliance

Demonstrates the impact of transformative technology on cell therapy manufacturing.

Charles Sternberg, Assistant Editor 03.24.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Process Development

ProBioGen, Nobelpharma Enter Mfg. Agreement for Vax Project

To leverage ProBioGen’s vaccine development platform consisting of its AGE1.CR.pIX suspension cell line and its high performance cell culture medium.

Kristin Brooks 03.24.21

Breaking News | cGMP Manufacture | Formulation Development | Industry News

Piramal Pharma Solutions, Plus Therapeutics Ink MSA  

Piramal to perform services related to the development, manufacture, and supply of Plus Therapeutics’ RNL-Liposome Intermediate Drug Product.

Kristin Brooks 03.24.21

Genopis Renamed Wacker Biotech US

Plasmid DNA contract manufacturer was recently acquired by Wacker.

Tim Wright, Editor, Contract Pharma 03.19.21

WuXi Biologics to Acquire CMAB Biopharma Group

Will increase 7000L drug substance capacity (MFG21) and drug product capacity (DP11) for liquid and lyophilization within its global manufacturing network.

Kristin Brooks 03.18.21